Correlation Between Biofrontera Warrants and Carmell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and Carmell Therapeutics, you can compare the effects of market volatilities on Biofrontera Warrants and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Carmell Therapeutics.

Diversification Opportunities for Biofrontera Warrants and Carmell Therapeutics

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Biofrontera and Carmell is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Carmell Therapeutics go up and down completely randomly.

Pair Corralation between Biofrontera Warrants and Carmell Therapeutics

Assuming the 90 days horizon Biofrontera Warrants is expected to generate 9.08 times more return on investment than Carmell Therapeutics. However, Biofrontera Warrants is 9.08 times more volatile than Carmell Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about 0.02 per unit of risk. If you would invest  2.21  in Biofrontera Warrants on September 2, 2024 and sell it today you would earn a total of  10.79  from holding Biofrontera Warrants or generate 488.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy50.32%
ValuesDaily Returns

Biofrontera Warrants  vs.  Carmell Therapeutics

 Performance 
       Timeline  
Biofrontera Warrants 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera Warrants are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Biofrontera Warrants showed solid returns over the last few months and may actually be approaching a breakup point.
Carmell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days Carmell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Carmell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Biofrontera Warrants and Carmell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofrontera Warrants and Carmell Therapeutics

The main advantage of trading using opposite Biofrontera Warrants and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.
The idea behind Biofrontera Warrants and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios